205 related articles for article (PubMed ID: 9174404)
1. RET in human development and oncogenesis.
Edery P; Eng C; Munnich A; Lyonnet S
Bioessays; 1997 May; 19(5):389-95. PubMed ID: 9174404
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
Smith DP; Eng C; Ponder BA
J Cell Sci Suppl; 1994; 18():43-9. PubMed ID: 7883791
[TBL] [Abstract][Full Text] [Related]
3. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
[TBL] [Abstract][Full Text] [Related]
4. RET mutations in multiple endocrine neoplasia type 2 and Hirschsprung disease.
Reynolds LF; Eng C
Curr Opin Pediatr; 1995 Dec; 7(6):702-9. PubMed ID: 8776023
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
Eng C; Mulligan LM
Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
Recent Results Cancer Res; 1998; 154():229-36. PubMed ID: 10027003
[TBL] [Abstract][Full Text] [Related]
7. Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.
Chappuis-Flament S; Pasini A; De Vita G; Ségouffin-Cariou C; Fusco A; Attié T; Lenoir GM; Santoro M; Billaud M
Oncogene; 1998 Dec; 17(22):2851-61. PubMed ID: 9879991
[TBL] [Abstract][Full Text] [Related]
8. RET oncogene.
Mak YF; Ponder BA
Curr Opin Genet Dev; 1996 Feb; 6(1):82-6. PubMed ID: 8791480
[TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
Hofstra RM; van der Luijt RB; Lips CJ
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2217-21. PubMed ID: 11757244
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease.
Borst MJ; VanCamp JM; Peacock ML; Decker RA
Surgery; 1995 Apr; 117(4):386-91. PubMed ID: 7716719
[TBL] [Abstract][Full Text] [Related]
11. Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
Takahashi M; Iwashita T; Santoro M; Lyonnet S; Lenoir GM; Billaud M
Hum Mutat; 1999; 13(4):331-6. PubMed ID: 10220148
[TBL] [Abstract][Full Text] [Related]
12. RET activation by germline MEN2A and MEN2B mutations.
Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
[TBL] [Abstract][Full Text] [Related]
13. The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.
Kusafuka T; Puri P
Pediatr Surg Int; 1997; 12(1):11-8. PubMed ID: 9035202
[TBL] [Abstract][Full Text] [Related]
14. ret protooncogene mutations and endocrine neoplasia--a story intertwined with neural crest differentiation.
Gagel RF
Endocrinology; 1996 May; 137(5):1509-11. PubMed ID: 8612478
[No Abstract] [Full Text] [Related]
15. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
[TBL] [Abstract][Full Text] [Related]
16. A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B.
Cosma MP; Panariello L; Quadro L; Dathan NA; Fattoruso O; Colantuoni V
Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):397-400. PubMed ID: 8670046
[TBL] [Abstract][Full Text] [Related]
17. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.
Romeo G; Ronchetto P; Luo Y; Barone V; Seri M; Ceccherini I; Pasini B; Bocciardi R; Lerone M; Kääriäinen H
Nature; 1994 Jan; 367(6461):377-8. PubMed ID: 8114938
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the RET proto-oncogene in Hirschsprung's disease.
Edery P; Lyonnet S; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékété C; Ponder BA; Munnich A
Nature; 1994 Jan; 367(6461):378-80. PubMed ID: 8114939
[TBL] [Abstract][Full Text] [Related]
19. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease.
Bordeaux MC; Forcet C; Granger L; Corset V; Bidaud C; Billaud M; Bredesen DE; Edery P; Mehlen P
EMBO J; 2000 Aug; 19(15):4056-63. PubMed ID: 10921886
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
Mulligan LM; Ponder BA
J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
[No Abstract] [Full Text] [Related]
[Next] [New Search]